Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    0.4%
    Check dated 2026-11-08T13:36:09.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The website’s displayed revision changes from v3.7.2 to v3.8.0, indicating an updated site release.
    Difference
    0.1%
    Check dated 2026-11-01T14:46:38.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide notice announces updates to NIH websites and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T17:21:16.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:34:36.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:38:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    There are no textual additions or deletions in the provided data; the record history content appears unchanged.
    Difference
    0.1%
    Check dated 2026-09-27T22:55:41.000Z thumbnail image

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.